Home/ Supplements/ Vitamin K/ Nutrient 950 with Vitamin K

Nutrient 950 with Vitamin K

product on market Capsule Pure Encapsulations Safety: 88/100
88/100

This product is generally safe

  • Niacin: 86mg is 2.5× the Tolerable Upper Intake Level (35mg)
  • Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 68% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains vitamins A, C, D, E, and K, which are supported by strong evidence for maintaining immune function, bone health, and antioxidant defense. These essential nutrients play critical roles in cellular repair and coagulation. The ingredient profile is associated with a high safety score of 88/100.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 86mg is 2.5× the Tolerable Upper Intake Level (35mg)

Folate: 667mg is 667.0× the Tolerable Upper Intake Level (1.0mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Nutrient 950 with Vitamin K
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
68%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
2250 mcg (250% DV)
Vitamin C
500 mg (556% DV)
12.5 mcg (63% DV)
Within RDA (0.8× RDA) 608 studies (A:16, B:251)
134 mg (893% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
125 mcg (104% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)
50 mg (4167% DV)
41.7× RDA — above typical dose 76 studies (A:0, B:33)
34.75 mg (2673% DV)
26.7× RDA — above typical dose 13 studies (A:0, B:1)
86 mg (538% DV)
Exceeds UL by 2.5× (UL: 35 mg) 196 studies (A:5, B:63)
20.5 mg (1206% DV)
15.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
667 mcg DFE (167% DV)
Exceeds UL by 667.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
500 mcg (20833% DV)
208.3× RDA — above typical dose 139 studies (A:1, B:44)
400 mcg (1333% DV)
13.3× RDA — above typical dose 27 studies (A:0, B:11)
200 mg (4000% DV)
40.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
150 mg (12% DV)
100 mcg (67% DV)
Within RDA (0.7× RDA) 245 studies (A:4, B:133)
100 mg (24% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
12.5 mg (114% DV)
1.1× RDA — within safe limits 263 studies (A:6, B:134)
100 mcg (182% DV)
1.8× RDA — within safe limits 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
2.5 mg (109% DV)
1.1× RDA — within safe limits 9 studies — no high-quality reviews
100 mcg (286% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
50 mcg (111% DV)
1.1× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
49.5 mg (1% DV)
250 mcg
2.1× RDA — within safe limits 275 studies (A:9, B:175)
7.5 mcg
Within RDA (0.1× RDA) 275 studies (A:9, B:175)
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
100 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
Proprietary Mixed Carotenoid Blend
425 mcg

Other Ingredients

Vegetarian Capsule Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: As a dietary supplement, take 3 capsules, 1–2 times daily, with meals.

Warnings & Precautions

Warning: Vitamin K may be contraindicated with Coumadin (Warfarin). If you are pregnant or lactating, have any health condition or are taking any medication, particularly blood thinning medication, consult your health professional before use.

Keep out of the reach of children.

Use only if safety seal is intact.

Formulation Notes

Multivitamin/mineral formula for daily wellness

Gluten-free, Non-GMO & Hypoallergenic

Gluten-free, Non-GMO & Hypoallergenic

Additional Information

Store in a cool, dry place.

Scan to learn about our hypoallergenic supplements

Contents may not fill package in order to accommodate required labeling. Please rely on stated quantity.

GFCO.org Certified gluten-free by the gluten-free certification organization, www.gluten.org

Metadata

Product Details

UPC / SKU7 66298 01035 9
DSLD Entry Date2022-11-22
Product TypeOther Combinations
FormCapsule
BrandPure Encapsulations
DSLD ID278004
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Pure Encapsulations View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.